New Insulin Glargine Approved; Late Dinner Bad for the Waistline?

(MedPage Today) — Mylan’s insulin glargine injection (Semglee, 100 units/mL) won full FDA approval for glycemic control in adult and pediatric patients with type 1 diabetes, as well as adults with type 2 diabetes.
The FDA listed more recalls…

Source link

Related posts

Most Primary Care Providers Screening Toddlers for Autism


Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program in Pediatric Units in Tertiary Care Teaching Hospital in Thailand


CDC: Coverage 94.7 Percent for Two Doses of MMR in 2018 to 2019


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World